Here is a structured clinical analysis based on the CT report findings for this 14-year-old girl:
CT Findings Summary
| Finding | Detail |
|---|
| Lesion size | 85 x 80 x 70 mm (~8.5 cm) |
| Character | Well-defined, encapsulated, purely cystic |
| Location | Midline pelvic cavity |
| Internal contents | No septations, no solid enhancing component |
| Bladder | Mild indentation on superior surface |
| Left ovary | Seen separately, abutting the lesion |
| Uterus | Bicornuate morphology (congenital anomaly) |
| Lymph nodes / ascites | None |
| Other organs | All normal |
Differential Diagnosis
Given the midline location, purely cystic nature, no solid components, and left ovary seen separately, the most likely diagnoses in a 14-year-old girl are:
- Ovarian cyst (most likely) - serous cystadenoma, simple follicular/functional cyst, or parovarian cyst. The left ovary abutting the lesion supports ovarian origin even if seen "separately."
- Urachal cyst - midline, anterior to bladder; possible given midline location.
- Lymphatic malformation (lymphangioma) - large simple cystic pelvic masses without septations.
- Mesenteric / omental cyst - possible but less likely given pelvic midline location.
- Paratubal (parovarian) cyst - common in adolescents, separate from the ovary.
The absence of any solid component, septations, or lymphadenopathy makes malignancy very unlikely, but cannot be excluded without surgery/histology at this size.
Recommended Next Steps
1. Immediate Investigation (Pre-operative workup)
Tumor markers (mandatory before any intervention):
- AFP (alpha-fetoprotein) - for germ cell tumors
- beta-hCG - dysgerminoma, embryonal carcinoma
- CA-125 - epithelial tumors
- LDH - dysgerminoma
- Inhibin A & B - juvenile granulosa cell tumor
- CEA - mucinous tumors
- Estradiol, testosterone if hormonal symptoms
A full tumor marker panel increases sensitivity and specificity. Note: elevated markers can occur in benign lesions; normal markers do not exclude malignancy.
Pelvic/Abdominal Ultrasound (USG):
- Better characterization of ovarian vs. non-ovarian origin
- Doppler to assess vascularity
- More sensitive than CT for thin septations
MRI pelvis (preferred over CT for further workup):
- Better soft tissue resolution
- Can distinguish ovarian from non-ovarian, and assess the congenital uterine anomaly (bicornuate uterus) more accurately
- No radiation (important in a 14-year-old)
2. Surgical Management
Indication for surgery: This lesion is large (>8 cm), causing bladder indentation, and has not been shown to resolve - surgical intervention is indicated.
Approach: Laparoscopic surgery (preferred)
- Minimally invasive laparoscopic ovarian cystectomy (cyst-sparing) is the gold standard in adolescents
- Goal: fertility-preserving, ovary-sparing surgery
- Avoid oophorectomy unless histology/intraoperative findings strongly indicate malignancy
- Intraoperative frozen section should be available
- If unilocular/simple cyst confirmed intraoperatively and markers negative, proceed with laparoscopic cystectomy
- Cystectomy is preferred over aspiration alone due to high recurrence rates with aspiration
Laparotomy may be needed if:
- Lesion is too large for laparoscopic extraction safely
- Intraoperative malignancy findings
- Rupture or torsion
If malignancy is found: Full staging - peritoneal lavage, biopsies, pelvic and periaortic lymph node sampling.
3. The Bicornuate Uterus
The incidentally found bicornuate uterus (a Mullerian duct fusion anomaly) should be noted and the patient counseled. It does not need immediate surgery at age 14, but:
- Needs monitoring for reproductive implications
- Gynecologic follow-up as she approaches reproductive age
- Associated with increased risk of miscarriage and preterm labor - relevant later in life
- MRI is the best modality to fully characterize the uterine anomaly
4. Post-operative Follow-up
If surgery is performed:
- Follow-up every 3-6 months for first 2 years, then annually for up to 5 years
- Tumor marker monitoring
- Ultrasound surveillance
Summary of Action Plan
| Priority | Action |
|---|
| Urgent | Tumor markers (AFP, beta-hCG, CA-125, LDH, inhibin) |
| Next | Pelvic MRI for better characterization |
| Definitive | Laparoscopic ovarian-sparing cystectomy |
| Concurrent | Pediatric/adolescent gynecologist referral |
| Long-term | Follow-up for ovarian cyst recurrence + bicornuate uterus counseling |
Important note: This is clinical guidance based on the imaging report. The actual management must be decided by the treating pediatric gynecologist or pediatric surgeon after examining the patient, reviewing all imaging, and considering tumor marker results. At 14 years, preserving ovarian function and fertility is a top priority.